• Profile
Close

Olanzapine for the prevention of postdischarge nausea and vomiting after ambulatory surgery: A randomized controlled trial

Anesthesiology May 15, 2020

Hyman JB, Park C, Lin HM, et al. - Researchers conducted this prospective, randomized, double-blind, parallel-group, placebo-controlled study in order to test the hypothesis that oral olanzapine is superior to placebo at preventing postdischarge nausea and vomiting. A single preoperative dose of olanzapine 10 mg was compared with placebo in adult female patients 50 years old or less, undergoing ambulatory gynecologic or plastic surgery with general anesthesia. All the 140 randomized patients were administered standard antiemetic prophylaxis with dexamethasone and ondansetron. As per outcomes, the risk of nausea and/or vomiting in the 24 h after discharge from ambulatory surgery reduces by about 60% with a slight increase in reported sedation when olanzapine, vs placebo, is provided with ondansetron and dexamethasone.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay